3 insiders reported 41 Form 4 transactions for Contineum Therapeutics, Inc. (CTNM) over the past 18 months (most recent 2026-07-02). Recent activity: Lorrain Daniel S. (Chief Scientific Officer) Buy 28,826 shares, Lorrain Daniel S. (Chief Scientific Officer) Sell 28,826 shares, Lorrain Daniel S. (Chief Scientific Officer) Buy 4,183 shares, Lorrain Daniel S. (Chief Scientific Officer) Sell 5,852 shares, Lorrain Daniel S. (Chief Scientific Officer) Sell 2,501 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Buy | 28,826 | $29,114 |
| 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 28,826 | $462,288 |
| 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Buy | 4,183 | $4,225 |
| 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 5,852 | $91,682 |
| 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 2,501 | $40,608 |
| 2026-07-01 | Stengone Carmine N. | CEO and President | Buy | 7,500 | $7,575 |
| 2026-07-01 | Watkins Tim | CMO & Head of Development | Buy | 10,833 | $48,748 |
| 2026-07-01 | Stengone Carmine N. | CEO and President | Buy | 2,500 | $3,150 |
| 2026-07-01 | Watkins Tim | CMO & Head of Development | Sell | 10,833 | $173,590 |
| 2026-07-01 | Stengone Carmine N. | CEO and President | Sell | 10,000 | $160,080 |
| 2026-06-01 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 4,170 | $54,862 |
| 2026-05-01 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 300 | $4,152 |
| 2026-05-01 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 3,870 | $50,542 |
| 2026-04-06 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 4,170 | $56,014 |
| 2026-03-02 | Watkins Tim | CMO & Head of Development | Buy | 3,611 | $16,250 |
| 2026-03-02 | Watkins Tim | CMO & Head of Development | Sell | 3,611 | $54,237 |
| 2026-03-02 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 4,170 | $62,592 |
| 2026-02-26 | Stengone Carmine N. | CEO and President | Buy | 4,400 | $5,544 |
| 2026-02-26 | Stengone Carmine N. | CEO and President | Sell | 4,400 | $70,488 |
| 2026-02-26 | Stengone Carmine N. | CEO and President | Buy | 2,700 | $3,402 |
| 2026-02-26 | Stengone Carmine N. | CEO and President | Sell | 2,700 | $43,254 |
| 2026-02-26 | Lorrain Daniel S. | Chief Scientific Officer | Buy | 4,300 | $4,343 |
| 2026-02-26 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 4,300 | $68,929 |
| 2026-02-26 | Lorrain Daniel S. | Chief Scientific Officer | Buy | 3,824 | $3,862 |
| 2026-02-26 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 3,824 | $61,222 |
Source: SEC Form 4 filings · as of 2026-07-02